Cardiovascular disease continues to be the leading cause of death worldwide. But advances in heart-failure therapeutics have ...

Australia's Victoria state on Wednesday unveiled plans to develop an onshore messenger-RNA (mRNA) vaccine manufacturing facility and launched three mass coronavirus immunisation centres to speed up ...

Moderna Inc became the second U.S company to release data from a large study of its experimental vaccine, saying it was 94.5% effective against COVID-19.

The study builds on Dr Elias Sayour’s (University of Florida) earlier research and marks a key step toward a universal cancer vaccine that boosts immunotherapy’s effectiveness.

CAMBRIDGE, MA / ACCESS Newswire / November 3, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the first patient has ...

South African biopharmaceutical firm Biovac on Thursday opened a state-of-the-art product development laboratory in Cape Town ...

With a little help from the Gates Foundation, Biovac will boost Africa’s vaccine manufacturing capacity with its newly opened ...

Dynavax is paying $30 million upfront for global rights to Vaxart’s investigational oral COVID-19 vaccine candidate, positioning the biotech to see phase 2b data before placing a bigger bet on the ...

The birds are an unlikely example of how public health fights have shifted political dynamics in ways the U.S. is influencing and reckoning with.

Strand Therapeutics promotes Prashant Nambiar to CSO and appoints Ethan Cash as SVP, Head of Portfolio Management and Program ...

For patients with certain types of advanced lung or skin cancer, administration of SARS-CoV-2 mRNA vaccine within 100 days of starting ICIs is associated with increased overall survival.

Vaccine manufacturing is challenged by stringent global regulations, essential for ensuring safety and efficacy, with ...